Condition
Haemophilia A clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Haemophilia A clinical trials that are recruiting, at sites in 32 countries (most in Germany (5), France (4), Italy (3)). By phase: Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 32Countries
Newest Haemophilia A clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Denecimig (Mim8) for adults with acquired Haemophilia A | Phase 3 | Iowa City, Iowa and 82 other locations | Recruiting | Sep 21, 2026 |
| Surgical Use of Efanoctocog alfa in Hemophilia A Patients | — | Bron | Recruiting | Jul 23, 2026 |
| SCT800 for preventing and treating bleeds in previously untreated severe hemophilia A patients | Phase 3 | Beijing, Beijing Municipality | Recruiting | Feb 27, 2026 |
| Different doses of Inno8 for adults with haemophilia A. | Phase 1 | Aurora, Colorado and 32 other locations | Recruiting | Oct 24, 2025 |
| Evaluating synovitis in adults with haemophilia A | — | Bonn, North Rhine-Westphalia | Recruiting | Apr 8, 2024 |
| Evaluating the effectiveness and safety of FVIII concentrates in young haemophilia A patients | — | Miami, Florida and 58 other locations | Recruiting | Oct 4, 2018 |
| Survey on the success of individualized treatment for haemophilia A | — | Frankfurt am Main, Hesse | Recruiting | Aug 4, 2014 |
All recruiting trials (7)
-
Denecimig (Mim8) for adults with acquired Haemophilia A
This study tests whether denecimig can be safe and helpful for adults newly diagnosed with acquired Haemophilia A.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
SCT800 for preventing and treating bleeds in previously untreated severe hemophilia A patients
This test tries SCT800, a recombinant factor VIII, as regular prevention and to treat bleeds in male patients with severe hemophilia A who haven't had prior factor VIII treatment.
-
Different doses of Inno8 for adults with haemophilia A.
This trial will test different doses of the experimental medicine Inno8 in adults with haemophilia A to see if it is safe and how the body handles it.
-
Evaluating synovitis in adults with haemophilia A
This study looks at how often adults with hemophilia A experience joint inflammation caused by bleeding and how it affects their joint health.
-
Evaluating the effectiveness and safety of FVIII concentrates in young haemophilia A patients
This study is testing how well and safely a new treatment for hemophilia A works in young children who haven't had much treatment before.
-
Survey on the success of individualized treatment for haemophilia A
This study is testing whether a personalized high-dose treatment can help people with haemophilia A who have developed inhibitors against factor VIII and if certain lab tests can predict how well this treatment will work.
Related topics
Quick answers
How many Haemophilia A clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 32 countries. The most sites are in Germany (5 trials), France (4 trials), Italy (3 trials), Spain (3 trials), United Kingdom (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.